Showing results (1811-1820 of 2,571) with videos related to
Sort By:
Pageof 258
Journal of Drug Targeting|September 21, 2016
Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicinesNazanin Rahmanian, Morteza Eskandani, Jaleh Barar, et al.Journal of Drug Targeting|May 3, 2017
The application of polysaccharide-based nanogels in peptides/proteins and anticancer drugs deliveryLin Zhang, Jifei Pan, Shibo Dong, et al.Journal of Drug Targeting|April 28, 2017
Intracellular localisation of proteins to specific cellular areas by nanocapsule mediated deliveryHuabin Wang, Ligang Chen, Xianchao Sun, et al.Journal of Drug Targeting|October 30, 2009
Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybinXinru Li, Yanqing Huang, Xingwei Chen, et al.Journal of Drug Targeting|October 30, 2009
Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophagesNarumon Changsan, Athip Nilkaeo, Pethchawan Pungrassami, et al.Journal of Drug Targeting|October 30, 2009
Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal modelsJie Fu, Guangxing Bian, Bijun Zhao, et al.Journal of Drug Targeting|November 27, 2009
Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitisM Simonoska Crcarevska, M Glavas Dodov, G Petrusevska, et al.Journal of Drug Targeting|December 22, 2009
Liquid crystalline Pluronic 105 pharmacogels as drug delivery systems: preparation, characterization, and in vitro transdermal releaseRita Muzzalupo, Lorena Tavano, Fiore Pasquale Nicoletta, et al.Journal of Drug Targeting|December 17, 2009
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS virusesAbeer M Al-Ghananeem, Hayder Saeed, Rebecca Florence, et al.Journal of Drug Targeting|April 10, 2018
Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft modelsLin Yu, Yuqin Yao, Yuxi Wang, et al.Pageof 258